Kamke Trent G 4

What Happened

• Trent G. Kamke, Senior Vice President, Operations at Lemaître Vascular (LMAT), exercised options to acquire 2,625 shares at an exercise price of $35.48 ($93,135 total) on 2026-03-11 and immediately sold 2,625 shares in an open market transaction at $108.50 for total proceeds of $284,813. The filing also lists a derivative disposal of 2,625 shares at $0 for the same date.
• This series of transactions resulted in a sale of shares (routine insider sale following option exercise). Gross proceeds from the sale were about $284.8K versus the option exercise cost of about $93.1K (rough pre-tax spread ≈ $191.7K).

Key Details

• Transaction date: 2026-03-11 (reported on Form 4 filed 2026-03-13).
• Option exercise: 2,625 shares @ $35.48 (acquired) = $93,135.
• Open-market sale: 2,625 shares @ $108.50 (disposed) = $284,813.
• Derivative disposal: 2,625 shares @ $0 (disposed) — reported alongside the exercise/sale.
• Footnotes: F1 = shares acquired on exercise as reported in Table II; F2 = option is fully vested and exercisable.
• Shares owned after the transaction: not specified in the provided filing summary.
• Filing timeliness: filed two days after the transaction date (appears timely).

Context

• This pattern—exercising vested options and selling the same shares the same day—is commonly a cashless exercise or a way to monetize option gains; it often does not indicate a change in confidence but is a routine executive liquidity event.
• The zero-dollar derivative disposal likely relates to settlement mechanics (e.g., shares withheld to cover exercise obligations or taxes) as commonly recorded in Form 4s; the filing’s footnotes do not detail the exact settlement use.